Su Min Cho Abdullah Esmail Maen Abdelrahim
10.3389/fphar.2021.795381
Front Pharmacol
2021 Dec 16;12:795381.
braf, crc chemotherapy immunotherapy irinotecan, cetuximab metastasis swog vemurafenib
CC BY
https://pubmed.ncbi.nlm.nih.gov/34975492/
Case Reports
PMC8716546
34975492
Triple-Regimen of Vemurafenib, Irinotecan, and Cetuximab for the Treatment of BRAFV600E-Mutant CRC: A Case Report and Review
2021